Clinical trial · Interventional
Helical Tomotherapy as a Radiotherapy Technique for Treating Bone Metastases
NCT00168129CI-TRIAL-00005900completedPhase 1ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To assess the safety and efficacy of a single fraction of radiotherapy using helical tomotherapy to treat bone metastases.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bone Neoplasms | Bone Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Helical tomotherapy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- To deliver a single fraction of radiotherapy safely to patients with bone metastases using helical tomotherapy
Secondary outcomes (4)
- measure
- To assess and quantify the acute toxicity of patients with bone metastases treated with helical tomotherapy.
- measure
- To measure invivo dosimetry and compare delivered doses to computer-reconstructed dose distribution.
- measure
- To determine the maximum tolerated does of palliative radiation give with helical tomotherapy in a single fraction.
- measure
- To assess the efficacy (pain control) of radiotherapy given with helical tomotherapy.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * painful metastatic bone disease from any malignancy Exclusion Criteria: * previous RT to same area * contraindications to RT
References
Publications (0)
Data not yet available
No reference posted for this study.